Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FCOB04 PET Imaging in Neurodegenerative Diseases
NCT07470710Phase 1Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of 18F-FCOB04 in neurodegenerative diseases (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Regional standardized uptake value ratio at Day 1. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
18F-FCOB04
03
Conditions
neurodegenerative diseases
Beyond the preview
Go deeper on NCT07470710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07470710.